Edwards Lifesciences's total assets for Q2 2026 were $13.87B, an increase of 4.10% from the previous quarter. MX:EW total liabilities were $3.14B for the fiscal quarter, a 4.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.